0000080424 False False 0000080424 2025-10-24 2025-10-24 0000080424 us-gaap:CommonStockMember 2025-10-24 2025-10-24 0000080424 exch:XNYS 2025-10-24 2025-10-24 0000080424 pg:A0.110NotesDue2026Domain 2025-10-24 2025-10-24 0000080424 pg:A3.25EURNotesDue2026Domain 2025-10-24 2025-10-24 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-10-24 2025-10-24 0000080424 pg:A1.200NotesDue2028Domain 2025-10-24 2025-10-24 0000080424 pg:A3.150EURNotesDue2028Domain 2025-10-24 2025-10-24 0000080424 pg:A1.250NotesDue2029Domain 2025-10-24 2025-10-24 0000080424 pg:A1.800NotesDue2029Domain 2025-10-24 2025-10-24 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-10-24 2025-10-24 0000080424 pg:A0.350NotesDue2030Domain 2025-10-24 2025-10-24 0000080424 pg:A0.230NotesDue2031Domain 2025-10-24 2025-10-24 0000080424 pg:A3.250EURNotesDue2031Domain 2025-10-24 2025-10-24 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-10-24 2025-10-24 0000080424 pg:A3.200EURNotesDue2034Domain 2025-10-24 2025-10-24 0000080424 pg:A1.875NotesDue2038Domain 2025-10-24 2025-10-24 0000080424 pg:A0.900NotesDue2041Domain 2025-10-24 2025-10-24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 24, 2025
___________________________________
The Procter & Gamble Company
(Exact name of registrant as specified in its charter)
___________________________________

Ohio (State or other jurisdiction of incorporation or organization) | 001-00434 (Commission File Number) | 31-0411980 (I.R.S. Employer Identification Number)
One Procter & Gamble Plaza Cincinnati, Ohio 45202
(Address of principal executive offices and zip code)
(513) 983-1100
(Registrant's telephone number, including area code)

___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock without Par Value | PG | NYSE
0.110% Notes due 2026 | PG26D | NYSE
3.25% EUR Notes due 2026 | PG26F | NYSE
4.875% EUR Notes due May 2027 | PG27A | NYSE
1.200% Notes due 2028 | PG28 | NYSE
3.150% EUR Notes due 2028 | PG28B | NYSE
1.250% Notes due 2029 | PG29B | NYSE
1.800% Notes due 2029 | PG29A | NYSE
6.250% GBP Notes due January 2030 | PG30 | NYSE
0.350% Notes due 2030 | PG30C | NYSE
0.230% Notes due 2031 | PG31A | NYSE
3.250% EUR Notes due 2031 | PG31B | NYSE
5.250% GBP Notes due January 2033 | PG33 | NYSE
3.200% EUR Notes due 2034 | PG34C | NYSE
1.875% Notes due 2038 | PG38 | NYSE
0.900% Notes due 2041 | PG41 | NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 - Regulation FD Disclosure
On October 24, 2025, The Procter & Gamble Company (the "Company") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
Item 9.01 - Financial Statements and Exhibits
(d): The following exhibits are being filed herewith:

Exhibit No. |  | Description
99.1 |  | Informational Slides Provided by The Procter & Gamble Company dated October 24, 2025.
104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 24th day of October, 2025.

The Procter & Gamble Company
By: | /s/ Sandra T. Lane
Name: | Sandra T. Lane
Title: | Assistant Secretary

INDEX TO EXHIBIT(S)
99.1 - Informational Slides Provided by The Procter & Gamble Company dated October 24, 2025.